This webcast is targeted at laboratories who are planning to implement a new LIMS, either for the first time or as a replacement for an aging LIMS that is no longer meeting the organization's business needs. Where do you start and what evaluation factors are most important? We will answer those questions as well as providing advice that will help ensure you make the right LIMS selection...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces its continuing commitment to the next generation of researchers and scientists with a call for registrations for its SPRI Grants for Genomic Research. Reinforcing its dedication to providing streamlined genomic workflow solutions, the company will award up to eight grants in 2022...
The Franklin is the national institute developing disruptive new technologies designed to tackle major challenges in health and life sciences. The competition aims to make these technologies – and the expertise of Franklin scientists – available to a small company in the UK to help them overcome a specific research challenge. The winning company will take part in a 12-week residency starting in April 2023, working with Franklin scientists to use technologies at the cutting edge of the field...
Aseptic Process solutions specialist Telstar will be expanding its facilities with the construction of three additional modules, adjacent to the building where the headquarters are currently located. The result will be a modern industrial site based on a total floor area of 16,000 m2, which will accommodate all the current activity of the company in Catalonia. A total of 70% of the space will be intended for production plants...
RQM+, the leading MedTech service provider with the world’s largest global team of regulatory and quality experts, and portfolio company of Linden Capital Partners, has announced the acquisition of Jordi Labs. With these new capabilities, RQM+ provides comprehensive regulatory, quality, clinical and laboratory services, supporting market access throughout the entire product lifecycle for medical devices and diagnostics....
The COVID-19 pandemic has put a spotlight on the dangers of misinformation in the science industry. This phenomenon has been amplified with the popularity of forums and platforms that act as news distribution networks without a filter or editorial oversight. Here Aleiya Lonsdale, Head of Event at the largest laboratory event in the UK, Lab Innovations 2022, discusses how the lab community has tried to hold back against the tide of scientific misinformation.
Minderoo Foundation and Illumina, Inc. have announced a 40 million Australian dollar (US $27.8 million) partnership that will leverage the power of genomics to accelerate scientific understanding of marine systems and help marine conservationists make informed decisions. The three-year partnership demonstrates a shared commitment to conserving marine biodiversity and understanding the changing marine ecosystems on which people and national economies depend...
CloudLIMS, a leading SaaS company offering secure, configurable, high-quality lab informatics solutions, proudly announces that it has completed the Service Organization Control (SOC 2) Type II audit. An independent, third-party Certified Public Accounting (CPA) firm carried out the SOC 2 Type II audit at CloudLIMS. The third-party approval stamps our continued commitment to offer a Laboratory Information Management System (LIMS) with the best information security offered in the industry...
As a pioneer in the industry, FRITSCH have poured 35 years of experience in particle sizing technology into the new FRITSCH Technology Centre for Particle Sizing, combining it with the latest high-end technology. Covering an area of 240 m2 on three floors, the new building at the FRITSCH headquarters in Idar-Oberstein/Germany offers plenty of room for the entire FRITSCH particle sizing team, bringing together development and application technology...
Merck, a leading science and technology company, strengthens its manufacturing capabilities for single-use assemblies, a key technology for the production of Covid-19 vaccines and other lifesaving therapies, by investing more than € 130 million in Molsheim, France. The investment is the largest ever in the 50-year history of the site and will create more than 800 jobs by the end of 2028...
PhoreMost to deploy its SITESEEKER platform to identify novel targets for Roche’s discovery programmes. PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to 'Drugging the Undruggable®' disease targets, has announced it has entered into a multi-project target discovery collaboration with Roche, one of the world's leading biotechnology companies. Under the terms of the agreement, PhoreMost will receive an upfront payment and is eligible for preclinical success-based milestones...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces it has acquired ValitaCell Ltd. (“ValitaCell”), a biotechnology company that creates pioneering analytical products and technologies for the biopharmaceutical industry. Headquartered in Dublin, Ireland, ValitaCell creates analytical technologies and products for the biopharmaceutical industry with the goal of reducing new therapeutics' cost and time to market...
Waters Corporation announced it is providing both technology and expertise to help advance plant-based protein science in collaboration with researchers of the Plant Protein Innovation Center (PPIC) at the University of Minnesota. Waters scientists will work with PPIC researchers to develop a workflow for measuring the amino acid content of plant-based proteins using a Waters ACQUITY™ Premier UPLC System....
Learn about CRISPR technology’s impact on cell and gene therapies and drug discovery and discover tips and tricks for optimized CRISPR editing and screening. On September 20, 2022, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery. The 3-hour workshop brings together renowned genome editing experts from across industry and academia and comprises four interactive speaker sessions....
Benchling, the R&D Cloud powering the biotechnology industry, today launched the industry’s first full set of capabilities for designing, modelling, and studying both natural and chemically modified RNA in a single solution. As the biopharmaceutical industry increases its focus on developing RNA therapeutics, Benchling’s new RNA solution is the first purpose-built offering on the market to help R&D organizations accelerate the delivery of drug candidates...
Beckman Coulter Life Sciences, a global leader in laboratory automation and biotechnology innovation, announces a partnership with Flownamics to create an automated, on-line solution for bioprocess culture monitoring and control. This delivers a critical and practical update to the significant unmet need for automated, real-time cell analysis in the current bioprocessing environment....
Cansford Laboratories has made a significant investment in equipment at its in-house drug and alcohol testing laboratory in Cardiff, as part of its continuing development programme. The investment has been made in a new Robotic Automatic Liquid Pipetting Handler (RALPH) machine which will help the lab work more efficiently by allowing operators to perform separate processes, simultaneously....
Miniaturisation has existed for a while, but usually at a high cost to medical device manufacturers. When Manchester-based UK Robotics, a specialist in building integrated lab automation solutions for the life sciences, needed to create a new cost-effective two valve nanolitre microplate reagent dispenser, it turned to precision DC motor manufacturer maxon UK and Ireland for help...
EVONETIX LTD, the synthetic biology company bringing semiconductor technology to DNA synthesis, has announced the opening of its early access program for semiconductor synthesised DNA. Evonetix’s DNA synthesis capability brings together patented semiconductor chip design and proprietary, thermally controlled synthesis chemistry, which will be integral to the Company’s future gene synthesis platforms...
Agilent Technologies has announced that it is collaborating with METTLER TOLEDO to address one of the biggest concerns in any laboratory—error-prone sample preparation. This integrated solution allows the automatic and seamless transfer of weighing results and the associated metadata from METTLER TOLEDO LabX™ Balance software to Agilent OpenLab software...
The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd. from private investors. The Nottingham, UK-based company provides best-in-class recombinant albumin-based solutions. Recombinant human albumin is an important component for the biopharmaceutical industry required for various applications...
Olympus Corporation (“Olympus”) and EVIDENT Co., Ltd. ("Evident"), a wholly-owned subsidiary of Olympus announce that Olympus concluded a definitive agreement with Bain Capital Private Equity, LP (“Bain Capital”), regarding the transfer of Evident. Based on this agreement, all shares of Evident will be transferred to Bain Capital on January 4, 2023, subject to regulatory approvals and closing conditions....
This webcast is targeted at laboratories who are planning to implement a new LIMS, either for the first time or as a replacement for an aging LIMS that is no longer meeting the organization's business needs. Where do you start and what evaluation factors are most important? We will answer those questions as well as providing advice that will help ensure you make the right LIMS selection...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces its continuing commitment to the next generation of researchers and scientists with a call for registrations for its SPRI Grants for Genomic Research. Reinforcing its dedication to providing streamlined genomic workflow solutions, the company will award up to eight grants in 2022...
The Franklin is the national institute developing disruptive new technologies designed to tackle major challenges in health and life sciences. The competition aims to make these technologies – and the expertise of Franklin scientists – available to a small company in the UK to help them overcome a specific research challenge. The winning company will take part in a 12-week residency starting in April 2023, working with Franklin scientists to use technologies at the cutting edge of the field...
Aseptic Process solutions specialist Telstar will be expanding its facilities with the construction of three additional modules, adjacent to the building where the headquarters are currently located. The result will be a modern industrial site based on a total floor area of 16,000 m2, which will accommodate all the current activity of the company in Catalonia. A total of 70% of the space will be intended for production plants...
RQM+, the leading MedTech service provider with the world’s largest global team of regulatory and quality experts, and portfolio company of Linden Capital Partners, has announced the acquisition of Jordi Labs. With these new capabilities, RQM+ provides comprehensive regulatory, quality, clinical and laboratory services, supporting market access throughout the entire product lifecycle for medical devices and diagnostics....
The COVID-19 pandemic has put a spotlight on the dangers of misinformation in the science industry. This phenomenon has been amplified with the popularity of forums and platforms that act as news distribution networks without a filter or editorial oversight. Here Aleiya Lonsdale, Head of Event at the largest laboratory event in the UK, Lab Innovations 2022, discusses how the lab community has tried to hold back against the tide of scientific misinformation.
Minderoo Foundation and Illumina, Inc. have announced a 40 million Australian dollar (US $27.8 million) partnership that will leverage the power of genomics to accelerate scientific understanding of marine systems and help marine conservationists make informed decisions. The three-year partnership demonstrates a shared commitment to conserving marine biodiversity and understanding the changing marine ecosystems on which people and national economies depend...
CloudLIMS, a leading SaaS company offering secure, configurable, high-quality lab informatics solutions, proudly announces that it has completed the Service Organization Control (SOC 2) Type II audit. An independent, third-party Certified Public Accounting (CPA) firm carried out the SOC 2 Type II audit at CloudLIMS. The third-party approval stamps our continued commitment to offer a Laboratory Information Management System (LIMS) with the best information security offered in the industry...
As a pioneer in the industry, FRITSCH have poured 35 years of experience in particle sizing technology into the new FRITSCH Technology Centre for Particle Sizing, combining it with the latest high-end technology. Covering an area of 240 m2 on three floors, the new building at the FRITSCH headquarters in Idar-Oberstein/Germany offers plenty of room for the entire FRITSCH particle sizing team, bringing together development and application technology...
Merck, a leading science and technology company, strengthens its manufacturing capabilities for single-use assemblies, a key technology for the production of Covid-19 vaccines and other lifesaving therapies, by investing more than € 130 million in Molsheim, France. The investment is the largest ever in the 50-year history of the site and will create more than 800 jobs by the end of 2028...
PhoreMost to deploy its SITESEEKER platform to identify novel targets for Roche’s discovery programmes. PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to 'Drugging the Undruggable®' disease targets, has announced it has entered into a multi-project target discovery collaboration with Roche, one of the world's leading biotechnology companies. Under the terms of the agreement, PhoreMost will receive an upfront payment and is eligible for preclinical success-based milestones...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces it has acquired ValitaCell Ltd. (“ValitaCell”), a biotechnology company that creates pioneering analytical products and technologies for the biopharmaceutical industry. Headquartered in Dublin, Ireland, ValitaCell creates analytical technologies and products for the biopharmaceutical industry with the goal of reducing new therapeutics' cost and time to market...
Waters Corporation announced it is providing both technology and expertise to help advance plant-based protein science in collaboration with researchers of the Plant Protein Innovation Center (PPIC) at the University of Minnesota. Waters scientists will work with PPIC researchers to develop a workflow for measuring the amino acid content of plant-based proteins using a Waters ACQUITY™ Premier UPLC System....
Learn about CRISPR technology’s impact on cell and gene therapies and drug discovery and discover tips and tricks for optimized CRISPR editing and screening. On September 20, 2022, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery. The 3-hour workshop brings together renowned genome editing experts from across industry and academia and comprises four interactive speaker sessions....
Benchling, the R&D Cloud powering the biotechnology industry, today launched the industry’s first full set of capabilities for designing, modelling, and studying both natural and chemically modified RNA in a single solution. As the biopharmaceutical industry increases its focus on developing RNA therapeutics, Benchling’s new RNA solution is the first purpose-built offering on the market to help R&D organizations accelerate the delivery of drug candidates...
Beckman Coulter Life Sciences, a global leader in laboratory automation and biotechnology innovation, announces a partnership with Flownamics to create an automated, on-line solution for bioprocess culture monitoring and control. This delivers a critical and practical update to the significant unmet need for automated, real-time cell analysis in the current bioprocessing environment....
Cansford Laboratories has made a significant investment in equipment at its in-house drug and alcohol testing laboratory in Cardiff, as part of its continuing development programme. The investment has been made in a new Robotic Automatic Liquid Pipetting Handler (RALPH) machine which will help the lab work more efficiently by allowing operators to perform separate processes, simultaneously....
Miniaturisation has existed for a while, but usually at a high cost to medical device manufacturers. When Manchester-based UK Robotics, a specialist in building integrated lab automation solutions for the life sciences, needed to create a new cost-effective two valve nanolitre microplate reagent dispenser, it turned to precision DC motor manufacturer maxon UK and Ireland for help...
EVONETIX LTD, the synthetic biology company bringing semiconductor technology to DNA synthesis, has announced the opening of its early access program for semiconductor synthesised DNA. Evonetix’s DNA synthesis capability brings together patented semiconductor chip design and proprietary, thermally controlled synthesis chemistry, which will be integral to the Company’s future gene synthesis platforms...
Agilent Technologies has announced that it is collaborating with METTLER TOLEDO to address one of the biggest concerns in any laboratory—error-prone sample preparation. This integrated solution allows the automatic and seamless transfer of weighing results and the associated metadata from METTLER TOLEDO LabX™ Balance software to Agilent OpenLab software...
The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd. from private investors. The Nottingham, UK-based company provides best-in-class recombinant albumin-based solutions. Recombinant human albumin is an important component for the biopharmaceutical industry required for various applications...
Olympus Corporation (“Olympus”) and EVIDENT Co., Ltd. ("Evident"), a wholly-owned subsidiary of Olympus announce that Olympus concluded a definitive agreement with Bain Capital Private Equity, LP (“Bain Capital”), regarding the transfer of Evident. Based on this agreement, all shares of Evident will be transferred to Bain Capital on January 4, 2023, subject to regulatory approvals and closing conditions....